Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT01954043 |
| Title | A Pharmacokinetics (PK) Study of the Effects Rabeprazole and Rifampin on Dabrafenib in Subjects With BRAF V600 Mutation Positive Tumors |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | Yes |
| Sponsors | GlaxoSmithKline |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | GBR | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| GSK Investigational Site | Goodyear | Arizona | 85338 | United States | Details | |
| GSK Investigational Site | Dallas | Texas | 75201 | United States | Details | |
| GSK Investigational Site | Tacoma | Washington | 98405 | United States | Details | |
| GSK Investigational Site | Heidelberg | Victoria | 3084 | Australia | Details | |
| GSK Investigational Site | Melbourne | Victoria | 3004 | Australia | Details | |
| GSK Investigational Site | London | W1G 6AD | United Kingdom | Details |